Skip to main content
. 2017 Jan 5;12(3):435–442. doi: 10.2215/CJN.07510716

Table 3.

Association between treatment-limiting directive and surrogate decision-maker with treatments in the last month of life and site of death among patients with ESRD

Treatment Treatment-Limiting Directive Adjusted Risk Difference, % (95% CI) Surrogate Decision-Maker Adjusted Risk Difference, % (95% CI)
Absent % (n=21,364) Present % (n=9352) Absent % (n=25,221) Present % (n=5495)
Hospitalization 71 62 −7 (−8 to −6) 70 62 −4 (−6 to −3)
Intensive care unit admission 47 32 −12 (−13 to −10) 44 34 −5 (−6 to −3)
Mechanical ventilation 19 6 −10 (−11 to −9) 16 10 −2 (−3 to −1)
CPR 6 2 −3 (−3 to −2) 5 3 −1 (−2 to 0)
Gastrostomy tube 2 1 −1 (−1 to 0) 2 2 0 (0, 1)
Inpatient death 46 34 −9 (−10 to −8) 44 35 −4 (−6 to −3)
Hospice admission 23 33 5 (4 to 6) 25 31 1 (−1 to 2)
Dialysis discontinuation 27 41 6 (5 to 7) 30 41 2 (1 to 3)

Models adjusted for age, sex, race, duration of dialysis, length of nursing home stay, days in hospital in prior year, dialysis modality, functional status, diabetes, ischemic heart disease, heart failure, stroke, chronic liver disease, chronic lung disease, cancer, depression, dementia, impaired decision-making skills, hospital referral region spending quintile, treatment-limiting directive, and surrogate decision-maker, in addition to correlation of subjects within nursing home facilities. 95% CI, 95% confidence interval; CPR, cardiopulmonary resuscitation.